Earnings Call · Q3 FY2022·2022-11-03

Q3 22EPS +2.94%·Rev n/aQ2 22EPS -22.22%·Rev n/aQ1 22EPS -46.67%·Rev n/aQ4 21EPS -33.33%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

Amy Conrad — Investor Relations

Erik Holmlin — Chief Executive Officer

Christopher Stewart — Chief Financial Officer

+0.4%1d on move date−1.0% vs SPY3d0.0%5d+5.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access